High in vitro activity of synthetic 5-aminoimidazole-4-carboxamidrazones against Candida biofilms formation on nanohydroxyapatite by Gabriel, Carla et al.
High in vitro activity of synthetic 5-aminoimidazole-4-carboxamidrazones against Candida 
biofilms formation on nanohydroxyapatite 
C Gabriel1*, L Grenho2,3*, AM Dias4, AI Ribeiro4, MF Proença4, MH Fernandes5, FJ Monteiro2,3, 
MP Ferraz1,2, R Medeiros1,6, F Cerqueira1 
1FP-ENAS/CEBIMED, Universidade Fernando Pessoa, Porto, Portugal 
2INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal;  
3Faculdade de Engenharia, Departamento de Engenharia Metalúrgica e Materiais, Universidade 
do Porto, Porto, Portugal;  
4Centre of Chemistry, Department of Chemistry, University of Minho, Campus de Gualtar, 
Braga, Portugal 
5Faculdade de Medicina Dentária, Departamento de Farmacologia, Universidade do Porto, 
Porto, Portugal 
6Molecular Oncology GRP and Molecular Biology Laboratory–Virology Service, Portuguese 
Institute of Oncology (IPO), Porto, Portugal 
*Contributed equally 
 
Infection is currently regarded as the most severe complication associated to the use of 
biomaterials. A wide range of biomaterials used in clinical practice have been shown to support 
colonization and biofilm formation by Candida species, with important clinical repercussions 
[1]. The cells within biofilms exhibit significant tolerance to antifungal therapy and have the 
ability to withstand host immune defenses. In addition, it represents a reservoir for persistent 
sources of infections [2]. In a previous work, Ribeiro et al prepared and tested a series of 5-
aminoimidazole-4-carboxamidrazones and three of them displayed strong antifungal activity on 
yeast [3]. Therefore, in the present study, the activity of these three novel imidazole derivatives 
was evaluated against C. albicans and C. krusei biofilm formation on nanohydroxypatite 
(nanoHA), a well-known biocompatible ceramic [4]. Additionally, the cytotoxicity against 
human osteoblastic cells (MG63) was also assessed. Two approaches were applied: (1) to 
investigate anti-biofilm effect the components were simultaneously incubated with yeast 
suspension and the number of adherent cells on nanoHA surface was assessed after 24 h 
incubation and (2) to access the mature biofilm eradication ability, 24 h biofilms of Candida spp 
established on nanoHA were exposed to 5-aminoimidazole-4-carboxamidrazones for 24 h and 
the number of remaining viable microorganisms was determined. Using both approaches, the 
metabolic activity of MG63 was assessed after 24h and 48h incubation with 5-aminoimidazole-
4-carboxamidrazones. Concerning the results obtained, the presence of imidazole derivatives 
had a remarkable inhibitory effect on subsequent biofilm development by C. albicans and C. 
krusei on nanoHA surface. Moreover, the three tested 5-aminoimidazole-4-carboxamidrazones 
displayed potent in vitro activity against sessile yeast cells within biofilms, in a concentration-
dependent way. Roughly, C. albicans was more sensitive to the components. The metabolic 
activity of MG63 cells had shown a time and concentration-dependent cytotoxicity. Together 
these preliminary findings indicate that these imidazole derivatives display potent activity 
against C. albicans and C. krusei biofilms in vitro. Future studies should be conducted to 
employ the potential of these components for the treatment or, even better, for the prevention of 
Candida biofilm biomaterial-associated infections. 
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